top of page

BioVenture Voices Episode 36: Sofinnova Invetments' Jim Healy

  • 4 hours ago
  • 1 min read

He discusses learnings from his decades in venture at Sofinnova Investments including 'products vs platform', therapeutics areas of interest, modalities, and how he utilizes board seats and thinks about management teams.




Chapters

Intro and early life – 0:39

MD / PhD at Stanford – 5:10

Intro to venture – 9:39

Joining Sofinnova – 13:32

Product vs platform – 20:55

Board seats – 26:00

Investment strategy – 30:08

Therapeutic areas – 39:42

Regulatory predictability – 43:03

Management teams – 46:07

AI – 50:59

Modalities – 53:54

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

​

​Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page